Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001382536 | SCV001581370 | pathogenic | Congenital myasthenic syndrome 5 | 2020-10-08 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this variant affects COLQ protein function (PMID: 10665486). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in COLQ are known to be pathogenic (PMID: 22678886). This variant has been observed in individual(s) with clinical features of congenital myasthenic syndrome (PMID: 10665486). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln371*) in the COLQ gene. It is expected to result in an absent or disrupted protein product. |